Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1486, 2005-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Erlotinib dominates docetaxel for NSCLC
Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. :
Access to resources
Recommend
Docetaxel promising in NSCLC in the elderly
Inpharma, Vol. 1, Iss. 1552, 2006-01 ,pp. :
Erlotinib dominates docetaxel for NSCLC
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 540, 2007-01 ,pp. :
Docetaxel: impressive survival results in NSCLC
Inpharma, Vol. 1, Iss. 1244, 2000-01 ,pp. :
Docetaxel + cisplatin active in advanced NSCLC
Inpharma, Vol. 1, Iss. 1478, 2005-01 ,pp. :